
MODSIM Pharma is a drug discovery innovation company, founded in late 2018 as a spin-off from Uppsala University. They specialize in Structure-Based Drug Design (SBDD) using physics-based proprietary methods and molecular simulations. Their computational chemistry toolbox aims to accelerate Hit Identification, Hit-to-Lead, and Lead Optimization stages by efficiently identifying and designing optimized candidate compounds. MODSIM Pharma offers solutions like virtual compound library design, accurate modeling of pharmacological targets, and physics-based virtual screening. They integrate AI/ML approaches and optimize code for evolving hardware. Their business model includes flexible software licensing, computing services, scientific development, and expert consulting.

MODSIM Pharma is a drug discovery innovation company, founded in late 2018 as a spin-off from Uppsala University. They specialize in Structure-Based Drug Design (SBDD) using physics-based proprietary methods and molecular simulations. Their computational chemistry toolbox aims to accelerate Hit Identification, Hit-to-Lead, and Lead Optimization stages by efficiently identifying and designing optimized candidate compounds. MODSIM Pharma offers solutions like virtual compound library design, accurate modeling of pharmacological targets, and physics-based virtual screening. They integrate AI/ML approaches and optimize code for evolving hardware. Their business model includes flexible software licensing, computing services, scientific development, and expert consulting.